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Pathogenic bacteria utilize multiple approaches to establish infection and mediate their tox-
icity to eukaryotic cells. Dedicated protein machines deposit toxic effectors directly inside
the host, whereas secreted toxinsmust enter cells independently of other bacterial compo-
nents. Regardless of how they reach the cytosol, these bacterial proteins must accurately
identify their intracellular target before they can manipulate the host cell to beneﬁt their
associated bacteria.Within eukaryotic cells, post-translational modiﬁcations and individual
targeting motifs spatially regulate endogenous host proteins. This review focuses on the
strategies employed by bacterial effectors to associate with a frequently targeted location
within eukaryotic cells, the plasma membrane.
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INTRODUCTION
Pathogenic bacteria produce a wide array of virulence determi-
nants that are either secreted into the extracellular matrix or
“injected” directly into the target cell. These determinants can be
classiﬁed as toxins or effectors, with the distinction depending on
their mechanism of entry into the host cell, activity, and several
other factors (reviewed in Galan, 2009). However, this nomen-
clature is further clouded by the existence of toxins that release
effectors into the host upon toxin entry and protein cleavage
(Egerer and Satchell, 2010). Regardless of their entrance mech-
anism or catalytic activity, toxic effectors must correctly identify
the intracellular location of their target molecule once they reach
the interior of the host cell.
Bacterial effectors have been shown to mediate their activity
on many different targets within host cells, including proteins in
the nucleus, mitochondria, endoplasmic reticulum, cytoskeleton,
or plasma membrane (PM), as well as acting on the various host
membrane phospholipids themselves. In addition to mediating
cellular toxicity, numerous effectors combat host signaling path-
ways and clearance responses allowing for intracellular replication,
host cell remodeling, intercellular spread, and immune evasion.
Similar to how viruses hijack host cell processes utilizing mole-
cular mimicry, many bacterial effectors also mimic the catalytic
activities and targeting mechanisms of host proteins to ensure
proper function within their host.
Although hundreds have been identiﬁed, much of the current
research focus is on isolating new effectors as well as estab-
lishing catalytic activities and determining the roles in viru-
lence played by known effectors. However, with the advent of
advanced microscopic, genetic, bioinformatic, and biochemical
tools the regions and mechanisms responsible for governing
the intracellular location of these effectors are beginning to be
identiﬁed.
MECHANISMS OF TRANSLOCATING BACTERIAL EFFECTORS INTO HOST
CELLS
The most numerous and best-characterized effectors are those
translocated through the type III and IV secretion systems (T3SS,
T4SS). Proteins of the T3SS form a needle-like complex, or injecti-
some, that enables the bacteria to directly transport/inject effectors
from the bacterial cytoplasm to the host cytosol. T3SS effectors are
essential virulence factors for some of the most recognized human
and insect pathogens including Pseudomonas aeruginosa, Yersinia
pestis, Salmonella enterica, Shigella ﬂexneri, Bordetella pertussis,
Escherichia coli, non-O1non-O139Vibrio cholerae, andPhotorhab-
dus luminescens. In addition, many plant pathogens including
Xanthomonas spp., Erwinia spp., and Pseudomonas syringae uti-
lize T3SS effectors to mediate their colonization of and toxicity to
plant cells.
Similar to the activity and translocation of T3SS effectors, T4SS
deliver virulence proteins from their associated pathogens from
bacteria into host cells via an injectisome-like structure (Cascales
and Christie, 2003). However unlike T3SS, T4SS effectors are not
always directly deposited inside the host cytosol through the T4SS,
but can also be secreted into the extracellular milieu or released
into vacuoles within the cell depending on where their associated
pathogens are found in relation to the cell (Backert and Meyer,
2006; Fronzes et al., 2009). T4 secretion has been shown to deliver
toxins and effectors from pathogens that are strictly extracellular
includingHelicobacter pylori andB. pertussis aswell as bacteria that
replicate inside host cells including Legionella pneumophila, Bar-
tonella spp., and Coxiella burnetii. Therefore T4SS substrates must
contain specializedmechanisms to correctly identify their surface-
bound, extravacuolar, or otherwise intracellular targets following
secretion.
Similar to the array of functions performed by T3 and T4SS
effectors, bacterial protein toxins display a huge diversity in the
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mechanisms they employ to intoxicate and manipulate host cells.
A large number of these toxins utilize proteolysis within the
host to release effectors as well as, reveal, enhance, and/or acti-
vate their catalytic activities; a variety of secreted multifunctional
autoprocessing RTX toxins (MARTX) have recently been shown
to utilize autoprocessing to release multiple individual catalytic
effector domains into the host cytosol (Egerer and Satchell, 2010).
MARTX toxins are produced by many species of Vibrio as well
as an assortment of human and insect pathogens. These large
toxins are generally composed of a central region containing mul-
tiple effector domains that is ﬂanked by N- and C-terminal repeat
regions (Satchell, 2011).While these repeat regions are thought to
mediate host cell binding and translocation, the effector domains
are believed to carry out the actual cytotoxicity of their associated
toxins. Despite all of the MARTX toxins sharing this organization,
the deﬁning feature of this family of toxins is the presence of a
cysteine protease domain (CPD), which is responsible for cleav-
ing the full-length toxin into individual effector domains upon
binding host cell inositol hexakisphosphate (recently reviewed in
Egerer and Satchell, 2010). These cleavage events lead to the effec-
tor domains being released into the cytosol where they can then
identify their intracellular target and carry out their activities as
individual effectors. In this manner, the liberation of the MARTX
toxin effector domains into the cell mimics that of the delivery
of effectors through translocation by T3 and T4 secretion systems
(Figure 1).
MODIFYING MEMBRANES FOR INTRACELLULAR SURVIVAL:
SALMONELLA AND LEGIONELLA EFFECTORS
Many bacterial pathogens utilize effectors for initiation of intra-
cellular survival and replication. S. enterica serovar Typhimurium
stimulates host cell invasion and spread through translocationof at
least 39 effectors by two T3SS (T3SS1 and T3SS2). These effectors
modulate aspects of internalization, virulence, as well as the pro-
duction of a membrane-bound compartment where Salmonella
reside within the host cell. This compartment, the Salmonella-
containing vacuole (SCV), is a host cell derivedmembrane-bound
vacuole that, through the action of multiple T3SS effectors, pro-
vides a protected intracellular home for Salmonella to replicate and
evade degradation. In addition to establishing their connection to
infection dynamics, several speciﬁc functions have been attributed
to many of these effectors (for a recent comprehensive review of
Salmonella effectors and their activities and roles in disease, see
Agbor andMcCormick, 2011). Many of these effectors function at
different stages of the Salmonella infection cycle, therefore neces-
sitating stringent regulatory mechanisms to ensure proper timing
FIGURE 1 | Schematic summary of the toxic bacterial effectors that
target host cell plasma membranes. Shown are three central pathways
(T3SS, T4SS, MARTX) responsible for effector translocation into the host cell
and the intracellular locations of the effectors with lipidation motifs (jagged
lines at either end of an effector) or dedicated membrane localization domains
(triangles, T3SS; squares, T4SS; circles, MARTX). Potential hydrophobic
interactions with the membrane are indicated as yellow patches on the
effector. CC, coiled-coil domain; UB, ubiquitination site; SCV,
Salmonella-containing vacuole; LCV, Legionella-containing vacuole. See text
for details.
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of effector activity. To control this, in addition to having their
expression and translocation regulated temporally, the effectors
utilize host cell modiﬁcations and intrinsic motifs to control their
intracellular locations. Several of these spatial determinants have
been identiﬁed, particularly from effectors targeting the host cell
PM; SifA, SspH2, SseI, SopB, PipB2, and SseJ have all been found
associated with the PM, albeit through diverse means (Figure 1;
Table 1).
The most well characterized T4SS involved in translocation of
virulence factors, the Legionella Dot/Icm system, is also involved in
modifying host cell membranes. Similar to Salmonella, Legionella
evade the host immune response by modifying phagosomes to
prevent fusion with host lysosomes, thereby permitting replica-
tion inside the cell within Legionella-containing vacuoles (LCV;
Isberg et al., 2009). Several groups have shown that L. pneumophila
utilizes the Dot/Icm T4SS and >275 effectors to modulate nearly
every step of the infection process, including formation of the LCV
from host cell membranes (Segal et al., 1998; Vogel et al., 1998;
Nagai and Roy, 2003; Ensminger and Isberg, 2009; Isberg et al.,
2009;Zhu et al., 2011).Also like Salmonella,manyof theseDot/Icm
effectors are directed to the host PM and/or the LCV through host
cell modiﬁcations or by PM targeting motifs (Figure 1; Table 1).
Although they possess different methods of entry into the host
cell, bacterial effectors play diverse roles in the pathogenesis of
their cognate organisms, with many acting on host membranes
and membrane-associated proteins that are often the ﬁrst poten-
tial target upon entry. Accordingly, these effectors have evolved
an array of mechanisms to identify and interact with the PM.
Therefore, the focus of this review will be on the bacterial effectors
that target the host PM and will discuss the two main strategies
employed by these effectors to mediate these associations: local-
ization via host cell modiﬁcations and possession of dedicated
structural motifs sufﬁcient for PM localization (summarized in
Figure 1; Table 1).
HOST CELL MODIFICATIONS THAT MEDIATE PM
LOCALIZATION
Intracellular targeting in eukaryotic cells is often determined
through post-translational modiﬁcations, with lipidation serv-
ing as the major means to deliver proteins to the PM. Although
host cell enzymes carry out these modiﬁcations, bacterial effec-
tors have evolved mechanisms to mimic the recognition sites of
these enzymes in order to utilize these modiﬁcations for their
intracellular targeting.
Table 1 | Plasma membrane-associated bacterial effectors and their mechanisms of targeting.
Associated bacteria Effector(s) Secretion Targeting domain/mechanisma
Pseudomonas aeruginosa ExoS, ExoT T3SS Interior ∼22aa, L/charged-rich, hydrophobic and
electrostatic?
ExoU T3SS C-terminal 137aa, I/L/R rich
Yersinia spp. YopE T3SS ExoS, T-like MLD
YopO/YpkA T3SS Interior 70aa, L/I/K/R rich, hydrophobic and
electrostatic?
Salmonella spp. SifA T3SS C-terminal prenylation (farnesylation)
SspH2, SseI T3SS Palmitoylation, coiled-coils, and N-term ∼100aa
SopB T3SS Interior 22aa, hydrophobic rich, ubiquitination,
coiled-coils
SipA, SipB, SipC, SopD, SopE, SptP, PipB2,
SopD2, SseJ
T3SS Coiled-coil domain interactions?
Shigella ﬂexneri IpgD T3SS SopB-like MLD, ubiquitination?
Bordetella spp. BteA T3SS N-terminal 130aa, LRT
Photorhabdus luminescens Plu4750, Plu0882 T3SS BteA-like LRT
Plu1341, Plu1344, Plu3217, Plu3324 T1SS BteA-like LRT
Photorhabdus asymbiotica RTX toxin T1SS BteA-like LRT
Vibrio splendidus RTX toxin T1SS BteA-like LRT
Multiple phytopathogens AvrB, AvrRpm1, XopE1, XopE2, XopJ, HopF2 T3SS N-terminal sites for myristoylation (and palmitoylation)
AvrPphB-like T3SS Interior myristoylation site revealed by protease
cleavage
Legionella pneumophila AnkB, PelH/Lp2144 T4SS C-terminal prenylation (farnesylation)
Bartonella henselae BepA T4SS Internal 144aa, hydrophobic rich
Vibrio spp. and others RTX Rho Inactivation Domains T1SS ∼80aa 4-helix bundle, hydrophobic, and electrostatic
binding
RTX PMT-like domains T1SS 4HBM
Pasteurella multocida Pasteurella multocida toxin Unknown 4HBM
Clostridium spp. Clostridial glucosylating toxins Unknown 4HBM
aSee text for detailed descriptions and references.
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PRENYLATION OF C-TERMINAL CYSTEINE RESIDUES
The Salmonella effector SifA is a GTPase involved in SCV mem-
brane maintenance and contains a C-terminal CAAX-motif that
is necessary and sufﬁcient for targeting it to the PM of host cells
(Figure 2; Boucrot et al., 2003).Many eukaryotic proteins contain-
ing CAAX-motifs, including several Rho-GTPases, are modiﬁed
by host cell enzymes that attach a lipid isoprenyl moiety to the
conserved Cys residue (Gao et al., 2009). This post-translational
modiﬁcation serves to enhancemembrane localization by increas-
ing the overall hydrophobicity of the protein thereby inﬂuencing
the intracellular targeting of CAAX-motif-containing proteins.
Studies on transfected HEK 293T cells show that SifA is preny-
lated within the cell, while in vitro studies conﬁrm that preny-
lation occurs on the Cys residue within the SifA CAAX-motif
by protein geranylgeranyl transferase I (Reinicke et al., 2005).
Intriguingly, although deletion of SifA resulted in signiﬁcantly
attenuated survival and growth of Salmonella in macrophages, the
infection dynamics of Salmonella expressing SifA with a mutated
CAAX-motif were nearly indistinguishable from the wild-type
SifA expressing parental strain (Reinicke et al., 2005) despite the
SifA CAAX mutant showing decreased activity (Boucrot et al.,
2003). These results indicate that either the reduced levels of
SifA activity are sufﬁcient to maintain a typical infection or that
there are multiple overlapping mechanisms in place to ensure
SifA reaches its membrane-associated intracellular target during
infection.
Similar to SifA, many L. pneumophila effectors translocated
into the host via T4SS are prenylated, which delivers them to the
PM, LCV, or both, as in the case of AnkB. AnkB is a L. pneu-
mophila effector involved in binding polyubiquitinated bacterial
FIGURE 2 | Plasma membrane targeting motifs are not restricted to
specific locations within the various effectors.The dedicated membrane
localization domains (MLD) that have been identiﬁed are found at both termini
and in the interior of their effectors. Many of these MLDs contain stretches of
Ile/Leu/Val residues (yellow) to mediate hydrophobic membrane associations.
In addition, regions rich in basic residues (dark blue) can enhance membrane
binding by generating electrostatic interactions or serving as sites for host cell
ubiquitination. Sites for host cell lipidation (red) are also found at both termini
as well as on the interior of certain effectors, which is exposed following
cysteine protease cleavage. Several prenylated effectors contain motifs that
provide additional targeting information (gray) to identify speciﬁc locations
within the PM.
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proteins to the LCV (Price et al., 2009). These polyubiquitinated
proteins are essential for proper formation and maintenance of
the LCV, and accordingly, deletion of AnkB prevents L. pneu-
mophila replication within the host as well as disease (Price et al.,
2009, 2010a). When ectopically expressed in either mammalian
cells or the amebae Dictyostelium discoideum, AnkB was found
exclusively at the cell periphery. Peripheral localization was sub-
sequently shown to be dependent on a CAAX-motif (CVLC) at
the extreme C-terminus of AnkB, because mutation of this motif
abolished localization. Further, when these residues were fused to
a cytosolic protein, they were sufﬁcient to target the PM (Figure 2;
Price et al., 2010a). AnkB was also conﬁrmed to be prenylated by
a host cell farnesyltransferase and that this modiﬁcation was nec-
essary for PM targeting. Besides these lipidation events, Ivanov
et al. (2010) showed that AnkB contains a stretch of positively
charged residues that although not required to maintain mem-
brane association, were necessary for PM localization suggesting
that additional targeting informationmight determinemembrane
speciﬁcity. Interestingly, despite its exclusively peripheral localiza-
tionwhen ectopically expressed,AnkB is predominantly associated
with the outside of the LCVwhen translocated by the T4SS during
infection (Price et al., 2009, 2010a,b). This alternate localization
could indicate that AnkB is associating with another protein on
the LCV or that the changes in the LCV membrane caused by
additional Legionella proteins drive AnkB to the LCV (Yeung et al.,
2009). In addition to studies looking at speciﬁc phospholipids and
proteins present on each, these localization results show that the
outer membrane of the LCV retains sufﬁcient similarity to the
PM for lipidation to be employed by bacterial effectors to target
the LCV.
IN SILICO IDENTIFICATION OF PRENYLATED EFFECTORS
Apart from SifA and AnkB, several additional bacterial effectors
have been shown to contain putative CAAX-motifs responsible
for their intracellular targeting. Two recent bioinformatic analyses
looking at the sequenced genomes of four different Legionella iso-
lates for CAAX-motifs both identiﬁed 11 potentially farnesylated
effectors (Ivanov et al., 2010; Price et al., 2010b). Both studies tran-
siently expressed these effectors inmammalian cells and found that
only PelH localization appeared similar to that of AnkB,with all of
the others displaying various patterns of peri-nuclear localization
and co-localization with Golgi markers. Importantly, the CAAX-
motifs and host modiﬁcation were necessary for all patterns of
localization, as mutation of the Cys residue or treatment with
a prenylation inhibitor decreased membrane association for all of
the effectors (Table 1; Ivanov et al., 2010; Price et al., 2010b). In fur-
ther support of the overall importance of lipidation to the targeting
of Dot/Icm effectors, co-localization studies inD. discoideum show
that the host cell enzymes responsible for protein farnesylation are
associated with the LCV during infection (Al-Quadan and Kwaik,
2011). Therefore, effector lipidation can either occur within the
cytoplasm before the LCV is formed or locally on the surface of
the LCV once the effectors are released from the interior of the
LCV. These results show that many Dot/Icm proteins are local-
ized to various membranes within the cell through host-mediated
post-translational modiﬁcation and that targeting inﬂuences the
proper formation and maturation of the LCV during disease.
Due to the success of this bioinformatic approach in identifying
L. pneumophila prenylated effectors, further computational meth-
ods were used to predict additional similarly targeted effectors
(Al-Quadan et al., 2011). Analogous sequence and structure-based
approaches had previously been employed in order to establish a
deﬁned prenylation motif and identify putative farnesylated sub-
strates (Maurer-Stroh and Eisenhaber, 2005; London et al., 2011).
An initial in silico analysis of 17 sequenced mammalian or plant
pathogens using these techniques revealed the presence of 54 pro-
teins from 14 species containing a putative secretion system that
have a predicted CAAX-motif (Al-Quadan et al., 2011).While this
list contains known and putative effectors delivered by multiple
different pathways,38 proteinswere identiﬁed thatwere previously
unclassiﬁed as effectors and are likely targeted to the PM via their
associated CAAX-motifs. Given the commonality of prenylation
as a PM targeting mechanism used by bacterial and eukaryotic
proteins as well as the volume of genome sequence data avail-
able, applying these sorts of predictions to larger data sets will
undoubtedly be useful in the preliminary stages of identifying
novel effectors and PM-targeted proteins.
N-TERMINAL CYSTEINE PALMITOYLATION
Similar to prenylation by geranylgeranyl transferases, other host
enzymes catalyze the reversible fusion of palmitic acid or simi-
lar lipids to N-terminal Cys residues through amide or thioester
linkages. These reactions, termed palmitoylation, are mediated
by palmitoyl acyl transferases and have been shown to enhance
the PM association of both eukaryotic and bacterial proteins
(Resh, 1994). Two Salmonella T3SS effectors, SspH2 and SseI,
have recently been shown to require palmitoylation to target the
host PM (Figure 2; Hicks et al., 2011). SspH2 and SseI contain
N-terminal consensus palmitoylation motifs and require the Cys
residue for lipidation, PM localization, and effector activity (SseI;
Hicks et al., 2011). Interestingly, both SspH2 and SseI contain
additional information required for proper lipidation and local-
ization (Figure 2). Fusion of the palmitoylationmotif of SspH2 to
a non-palmitoylated or PM-associated Salmonella effector did not
result in PM localization or palmitoylation. Also, although full-
length SseI fused to GFP localized to the basolateral side of the PM
of polarized cells, a truncated version of SseI-GFP was found at
the apical PM (Hicks et al., 2011). Therefore, palmitoylation alone
was not sufﬁcient to properly target either effector to its correct
intracellular destination indicating that further study is necessary
to fully understand their mechanisms of targeting.
MYRISTOYLATION MEDIATED TARGETING
Besides attachment of lipid moieties to Cys residues during preny-
lation or palmitoylation, host cell enzymes can also lipidate Gly
residues to enhance the hydrophobicity of proteins. This lipida-
tion, myristoylation, is catalyzed by N -myristoyltransferase and
involves the covalent linkage of C14 fatty acid (myristate) to Gly
residues at the extreme N-terminus of a protein (Boutin, 1997; for
a more detailed description of the consensus recognition motif
see Martin et al., 2011). Similar to palmitoylation, myristoylation
can also inﬂuence the intracellular localization of proteins and
the two modiﬁcations are often combined to ensure targeting and
association with the PM (Resh, 1994). Many Ras family members,
Frontiers in Cellular and Infection Microbiology www.frontiersin.org May 2012 | Volume 2 | Article 75 | 5
Geissler Plasma membrane-associated bacterial effectors
frequent targets of T3SS effectors, utilize myristoylation and/or
palmitoylation to enhance their membrane binding (Roy et al.,
2000). Comparisons of the extreme N-terminal regions of sev-
eral plant pathogen-secreted effectors with their targets show the
presence of lipidation sites on both effector and target, suggesting
that analogous modiﬁcations deliver each to shared sites within
the cell.
Sequence homology searches have identiﬁed a large number of
effectors (>20) produced by phytopathic species of P. syringae and
Xanthomonas that contain putativemyristoylation sites (Nimchuk
et al., 2000; Robert-Seilaniantz et al., 2006; Thieme et al., 2007).
Subsequent studies looking at the importance of the Gly within
the myristoylation site of many of these proteins (including, but
not limited to, AvrB, AvrRpm1, XopE1, XopE2, XopJ, or HopF2)
found thatmutants lacking this Glywere no longer PM-associated,
functioned in plants, or lipidated in vitro (Figure 2; Nimchuk
et al., 2000; Robert-Seilaniantz et al., 2006; Thieme et al., 2007).
Interestingly, putative palmitoylation sites are found immediately
adjacent to the myristoylation sites within most of these effec-
tors. Mutation of the palmitoylated Cys within these sites on P.
syringae AvrB or AvrRpm1 did not abolish PM association or
activity like removal of the myristoylated Gly, although the Cys
mutants displayed partially reduced activity and membrane asso-
ciation (Nimchuk et al., 2000). These varying effects on activity can
be explained by the observation thatmyristoylation often precedes
palmitoylation, therefore myristoylation is required for complete
palmitoylation of these effectors and that, while myristoylation
is sufﬁcient for some activity, both modiﬁcations are needed for
full membrane association and activity. Importantly, the targets
of several of these effectors have been identiﬁed and are found at
the PM, thus explaining the requirement for lipidation (Axtell and
Staskawicz, 2003; Shao et al., 2003; Bosis et al., 2011; Wu et al.,
2011) (see Block and Alfano, 2011 for a review of all P. syringae
effector targets).
In addition to the effectors that possess “classical” N-terminal
sequences for lipidation, several classes of phytopathic effec-
tors have been identiﬁed that contain internal myristoylation
sites (Figure 2). These motifs are exposed following autocat-
alytic cleavage by CPDs attached to the effector (Nimchuk et al.,
2000). Homologs of the most well characterized of these effectors,
AvrPphB, can be identiﬁed within other plant-associated bacte-
ria (Dowen et al., 2009). In vitro biochemical studies on 7 of
the 13 homologs showed three unexpected ﬁndings: (1) not all
of the AvrPphB family members displayed autoprocessing; (2)
of those that were autoprocessed, not all of the cleavage events
led to exposure of lipidation sites; and (3) two homologs dis-
playing putative N-terminal myristoylation and palmitoylation
sites following cleavage were not lipidated (Dowen et al., 2009;
Fotiadis et al., 2012). Despite these discrepancies, mutation of the
Gly residue adjacent to the cleavage site within the AvrPphB-like
effectors abrogated PM localization and activity (Nimchuk et al.,
2000; Dowen et al., 2009; Wu et al., 2011). Thus, although many
of these effectors initially mask their targeting motifs, they ulti-
mately behave similarly to other“classically”lipidated effectors and
identify the PM through enhanced N-terminal hydrophobicity.
Altogether, despite signiﬁcant differences in the composition of
plant andmammalian cell membranes, an array of effectors utilize
multiple types of lipidation by host cell enzymes in order to mod-
ulate their delivery to the host PM where they can mediate their
function and beneﬁt their cognate bacterial pathogens.
PROTEINS WITH DEDICATED DOMAINS FOR MEMBRANE
LOCALIZATION
Similar to the diversity of lipidation-mediated targeting mech-
anisms employed within the host cell, several classes of post-
translational modiﬁcation independent PM targeting domains
have been identiﬁed within eukaryotic, viral, and bacterial pro-
teins. Homologous to the variety of host cellmodiﬁcations utilized
by bacterial effectors, several different dedicated PM targeting
structural motifs are present within effectors released by MARTX
toxins, T3SS, and T4SS. It is important to note that, in addition to
the effectors and domains described below, a number of effectors
and toxins are directly inserted into the PM as integral membrane
proteins through trans-membrane domains (e.g., Tir, diphtheria
toxin, etc.; Kenny et al., 1997; Zhao and London, 2005). However
because of their prevalence and diversity, this review focuses on the
mechanisms utilized by effectors tomediate peripheral attachment
to the PM.
SMALL, HYDROPHOBIC DOMAINS FOR MEMBRANE BINDING
Many bacterial effectors target host cell Rho family GTPases that
are responsible for modulating numerous intracellular signaling
pathways. These effectors function to either activate or inactivate
the Rho proteins, thereby altering host signaling to beneﬁt the
associated bacteria. Active Rho-GTPases are typically membrane-
associated; therefore effectors have had to devise strategies to
accurately target these membranes to subvert Rho signaling activ-
ity. P. aeruginosa ExoS and ExoT and Yersinia spp. YopE have been
shown to act as GTPase-activating proteins (GAPs) on substrates
within the ER-Golgi network in the peri-nuclear region of the cell
(Black and Bliska, 2000; Kazmierczak and Engel, 2002; Krall et al.,
2002, 2004). A shared membrane localization domain (MLD) has
been identiﬁedwithin all three of these effectors that is responsible
for mediating their initial association with the PM immediately
following translocation, then with the ER-Golgi following traf-
ﬁcking (Krall et al., 2004; Isaksson et al., 2009). Each of these
∼22-residue conserved MLDs are rich in Leu residues, contain
multiple charged residues (R/K, D/E), and possess at least one
highly hydrophobic residue (Phe; Figure 2; Table 2). Deletion or
mutation of any of theseMLDs signiﬁcantly reduced the virulence
of either P. aeruginosa (Zhang and Barbieri, 2005) or Y. pseudotu-
berculosis (Isaksson et al., 2009), emphasizing the importance of
these domains for effector activity.
Although direct membrane association has not been shown,
mutagenesis studies and alpha-helical predictions on ExoS com-
bined with structural evidence from YopE suggest how these
interactions may occur. The crystal structure of YopE shows that
the MLD is surface exposed, largely unstructured, and contains a
short (ﬁve residues) β-sheet (β3) and a portion of an α-helix (α2;
Birtalan et al., 2002). Mutagenesis studies on ExoS show that sub-
stitution of the conserved Leu residues inMLDExoS forAsn had the
same effect on membrane binding as deletion of the entire MLD,
whereas substitutions of the twoArg residues forAsn abolishedPM
localization but did not affect the overall percentage of membrane-
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Table 2 | Amino acid sequences of the known bacterial effector-membrane localization domainsa.
ExoS/ExoT/YopE_consensus GLLSRLGAAL-RPFVAII-WL
SopB/IpgD ALAGEAVSLKLVSVGLLTASNI
BepA ELKKTLIPKETLVPLTKLEIAEMVAEDAFVHTCRDQICSLSKIVYGSQGVLNKNIIEIIKNPSKGQQLATQIERTPYSVH
SLAGFDLICFKTGARVRAEKHVALLSCAVANFTHAVKHARQEITKEHQAEQNRLRQEVPMPS
ExoU LADTPERLAWLAAELNHADNVDHQQLLDAMRGQTVQSPVLAAALAEAQRRKVAVIAENIRKEVIFPSLYRPGQPD
SNVALLRRAEEQLRHATSPAEINQALNDIVDNYSARGFLRFGKPLSSTTVEMAKAWRNKEFT
4HBM_consensus MELMSKDELKKAASVFGKPIGESYQAILDALEEYHNLSGNTADYELEQVEKLFELNKQIDGYLLEHPD
SGRNPALTQLKEQLNTRL
BteA-like LRT_consensus LL+QGNK+FIDSTKR+LG+L+TD+PSKAL+AVRE+F+QTQSQPDE –
QHVLQLEQA+AHWQQHDPKEFAQRS+LVK+LRFEMG
YpkA HERISQHWQNPVGELNIGGKRYRIIDNQVLRLNPHSGFSLFREGVGKIFSGKMFNFSIARNLTDTLHAAQK
aSee text for further clariﬁcation of mechanisms and references.
associated ExoS (Zhang and Barbieri, 2005; Zhang et al., 2007). In
addition, helical wheel predictions on ExoS show that the MLD
forms an amphipathic helix with the Leu residues found on one
face, whereas the charged residues are on another (Zhang et al.,
2007). These ﬁndings indicate that the Leu residues possiblymedi-
ate binding to all cellular membranes while the charged residues
act to enhance PM interactions,possibly through electrostatic con-
tacts. AlthoughMLDYopE has been crystallized, because it is bound
to its chaperone in the crystal the in vivo orientation is not discern-
able (Birtalan et al., 2002). Although it is unlikely, in the absence
of evidence showing direct membrane association and because
amphipathic helices are often involved in protein–protein interac-
tions, it is also possible that these MLDs could be responsible for
binding a host membrane-associated protein.
The Salmonella T3SS effector, SopB, incorporates both a struc-
tural motif and host cell modiﬁcation to regulate its intracellular
location. SopB is a phosphoinositol phosphatase whose activity
controls both the initial stages of SCV formation and maturation
through hydrolysis of different host cell phospholipids. Hydroly-
sis of the phospholipids decorating the SCV leads to alterations in
SCV membrane charge and host signaling cascades (Hernandez
et al., 2004; Mason et al., 2007; Mallo et al., 2008; Bakowski et al.,
2010). Immediately following translocation into the cell, SopB is
found at the PM where it is ubiquitinated by host enzymes (Patel
et al., 2009). Mutation of the residues required for SopB ubiq-
uitination blocked delivery to the SCV leading to PM-retention,
indicating that ubiquitination, unlike lipidation-mediated deliv-
ery to the PM, is likely responsible for removing SopB from the
PM and that another mechanism was involved in PM targeting.
In silico searches of SopB for trans-membrane domains that might
mediate membrane binding led to the discovery of a 22-residue
long region required for PM association following translocation
into the cell (Figure 2). This region, in addition to sharing the
same size as the MLDs from ExoS, ExoT, and YopE, is also rich in
Leu/Val/Ser residues and is thought to mediate its attachment to
themembrane through strong hydrophobic interactions (Table 2).
Similar to ExoS,ExoT,andYopE,deletion of this domain abrogated
PM targeting and ubiquitination of SopB (SopBΔ288–309). Fur-
ther, Salmonella expressing SopBΔ288–309 were unable to invade
or replicate in host cells and were unable to modulate intracel-
lular signaling. Importantly, puriﬁed SopBΔ288–309 retained near
wild-type phosphatase activity in in vitro assays, indicating that
intracellular targeting and catalytic activity are separable. These
data show that SopB utilizes a short hydrophobic sequence for
PM localization and that this domain is necessary for Salmonella
infection (Patel et al., 2009). Interestingly, a functionally homol-
ogous effector translocated by Shigella, IpgD, contains a highly
similar sequence, suggesting that this is a shared motif employed
for targeting phosphoinositol phosphatases to vacuoles generated
by intracellular pathogens.
THE T4SS EFFECTOR BepA CONTAINS AN MLD
Apart from lipidation, other T4SS effectors contain dedicated
targeting motifs to mediate phospholipid binding and their intra-
cellular location. While they are not found at the PM, the L.
pneumophila effectors SetA, SidM/DrrA, SidC, LidA, and LpnE
all bind speciﬁc phosphatidylinositols within the cell in order to
associate with the LCV (Yeung et al., 2009; Jank et al., 2012). In
addition to these and the prenylated L. pneumophila T4SS effec-
tors that are discussed above, a 142aa region of the Bartonella
henselae T4SS effector BepA (305–446) has been shown to be
necessary and sufﬁcient for PM-binding, indicating that it is a
dedicated MLD (Figure 2; Schmid et al., 2006). Like the previ-
ously described T3SS effector MLDs that associate with the PM,
MLDBepA contains a high percentage (25%) of highly hydrophobic
(I, L,V) residues suggesting that membrane bindingmay bemedi-
ated through hydrophobic contacts (Table 2). Interestingly, BepA
is responsible for preventing endothelial cell apoptosis that likely
permits chronic B. henselae infection, and BepA PM localization
is necessary for this activity (Schmid et al., 2006). Determining the
mechanismof PMassociation by BepAwill therefore be important
in further characterizing how this intracellular pathogen evades
clearance.
THE ExoU MLD AFFECTS CATALYSIS
In addition to those found in its other primary effectors, a dedi-
catedMLDwas recently identiﬁedwithin theP. aeruginosa effector
ExoU (Rabin et al., 2006). Like ExoS and ExoT, ExoU requires an
intact and functional MLD to retain full toxicity as strains secret-
ing ExoU with mutations in the MLD show decreased cytotoxicity
to HeLa cells and are less virulent in a mouse model of pneumo-
nia (Veesenmeyer et al., 2010). ExoU does not target Rho-GTPases
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like ExoS and ExoT, but is a phospholipase (Phillips et al., 2003).
Therefore, the MLD likely directs the catalytic domain of ExoU to
the interior face of the PM after translocation where its phospho-
lipase activity induces rapid cell lysis (Rabin et al., 2006). The ﬁnal
87 residues of ExoU encompass the MLD and have been shown
to be necessary and sufﬁcient to target GFP to the PM, although
inclusion of an additional 50 residues (550–687) enhances PM
localization (Figure 2; Rabin et al., 2006). Similar to the other
P. aeruginosa and Yersinia spp. effector MLDs, MLDExoU con-
tains I/L and Arg residues that are required for proper localization
(Table 2; Veesenmeyer et al., 2010). Interestingly, numerousmuta-
tions within the MLD that decrease PM association also decrease
the catalytic activity of ExoU, indicating that MLDExoU is not only
responsible formembrane association but affects catalysis directly,
possibly through substrate or cofactor binding (Veesenmeyer et al.,
2010). Further in vitro biochemical analysis and structural deter-
minations will be required to determine the exact mechanism of
how these activities are intertwined.
CONSERVATION OF A FOUR-HELIX BUNDLE MLD IN THREE TOXIN
FAMILIES
In an effort to further characterize the mechanism of action of
several MARTX toxin effectors, a deletion analysis revealed the
presence of a dedicated MLD within the N-terminal portion of
the V. cholerae Rho inactivation domain (RID; Figure 2; Geissler
et al., 2010). PSI-BLAST searches performed on this 85aa portion
of RID (MLDRID) identiﬁed 24 homologs of this sub-domain:
nine MARTX RIDs; Pasteurella multocida mitogenic toxin (PMT)
and nine PMT-like MARTX effector domains; and ﬁve Clostridial
glucosylating toxins (CGTs; Figure 3A; Geissler et al., 2010, 2012).
These homologs were therefore found associated with three differ-
ent toxin families from a diverse collection of bacteria (Figure 3B)
andwhile themechanisms of intoxication employed by these fami-
lies are different, the intracellular targets of all three types of toxin
are found at the membrane; PMT acts on several Gα-subunits
of different G-protein coupled receptors (Orth et al., 2009), the
CGTs inactivate PM-bound Rho-GTPases (Just et al., 1995), and
the RIDs likely act on an as yet unidentiﬁed target in the PM
to inactivate RhoA (Sheahan and Satchell, 2007; Geissler et al.,
2010). Interestingly, RIDΔMLD retained its cell-rounding ability
when expressed at high levels during transient transfection, but
was no longer toxic when delivered at more physiological levels
(Geissler et al., 2010). Furthermore, despite retaining their full
catalytic activities, disrupting the MLD from either PMT or TcsL
abolished toxicity to tissue culture cells (Mesmin et al., 2004;Kami-
tani et al., 2010). These data show that while the catalytic site and
enzymatic activities of each family of toxin are not linked to the
MLDs, as in the case of ExoU, enhancing the ability of each toxin
to identify its target is essential for toxicity.
The homology of MLDRID with PMT is conﬁned to a region
that is necessary and sufﬁcient for PMTmembrane targeting (Kita-
dokoro et al., 2007) and the initial 15aa of the homologous regions
from TcsL and TcdB are required for full toxicity and in vitro lipo-
some binding, suggesting that they were involved in PM associa-
tions (Mesmin et al., 2004). In support of these ﬁndings and similar
to other MLDs that have been discussed herein, GFP-fusions to
putative MLDs from each toxin family displayed signiﬁcant PM
localization and were found in the membrane fraction following
cellular fractionation (Kitadokoro et al., 2007; Geissler et al., 2010,
2012; Kamitani et al., 2010).
While the amino acid sequence similarities between the MLD
homologs from the different toxin families is relatively low
(∼40%), each of these domains likely shares a conserved over-
all structure (Figures 3A,B; Table 2). The crystal structures of the
catalytic C-terminal portion of PMT and the glucosyltransferase
domains from TcdA, TcdB, TcsL, and TcnA show that each MLD
is composed of four closely packed α-helices that are connected
by short loop regions (Reinert et al., 2005; Kitadokoro et al., 2007;
Ziegler et al., 2008; Pruitt et al., 2012). In addition, structural pre-
dictions performed onmany of theVibrio MARTX effector MLDs
showed similar four helical bundles (Figure 3C; Geissler et al.,
2010). Therefore, to distinguish these MLDs from those produced
by T3 and T4SS effectors, the members of this family of domains
are referred to as 4-helical bundle MLDs (4HBM; Geissler et al.,
2012). Several studies using structure- andhomology-basedmuta-
genesis and structural modeling have provided insight into the
mechanism of PM-binding by the 4HBMs. These studies show
that individual residues involved in either maintaining the 4-helix
bundle or generating a positively charged surface are essential for
proper localization (Geissler et al., 2010, 2012; Kamitani et al.,
2010). While maintenance of the bundle likely contributes to
the overall structure of the protein, individual surface exposed
residues likely play direct roles in protein-membrane association.
In support of this, mutation of basic residues within the Loop1–
Loop3 region (L1–L3) of several 4HBMs signiﬁcantly reduced
their ability to localize to the PM (Figure 3C; Geissler et al., 2010,
2012).
Positively charged surfaces of proteins oftenmediate electrosta-
tic interactions with negatively charged host cellmembranes; these
interactions are often enhanced by the insertion of hydrophobic
residues into the lipid bilayer (Arbuzova et al., 2000; Zhang et al.,
2003; Mulgrew-Nesbitt et al., 2006). That basic residues within
L1–L3 were required for proper PM localization and the observa-
tion that highly hydrophobic residues (I, L, F) were found in L1
of those 4HBMs that showed strong PM localization, suggested
that this region might be involved in mediating membrane bind-
ing. Transfection and in vitro studies showed that both basic and
hydrophobic residues within L1 are required for the 4HBMs to
fully associate with the host PM and negatively charged phospho-
lipids (Geissler et al., 2012). Therefore, those 4HBMs that contain
an L1–L3 region rich in basic and hydrophobic residues are more
capable of associating with the PM than those 4HBMs lacking
either type of residue (Geissler et al., 2012).
THE BteA-LIKE FAMILY OF LIPID RAFT-TARGETING MLDs
In contrast to the numerous effectors delivered byMARTX toxins,
T3 and T4SS, human pathogenic Bordetella species only secrete
one effector via their T3SS (Panina et al., 2005). This effector,
BteA, is a 658aa cytotoxin produced by all three of the human
pathogenic Bordetella species (B. bronchiseptica, B. pertussis, and
B. parapertussis). Upon translocation into a variety of host cells,
BteA induces non-apoptotic cell death and is thought to be a cen-
tral virulence factor because deletionof BteAabolishes cytotoxicity
and results in a phenotype indistinguishable from deletion of the
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FIGURE 3 | Despite the shared overall structure for membrane
associations by the four helical bundle membrane localization
domains, their primary amino acid sequences show significant
diversity. (A) Pairwise sequence alignment of all 24 of the currently
identiﬁed 4HBMs organized according to their sequence identity. A
schematic representation of the structure of the domains is depicted
below alignment. To highlight their locations on either loops or helices,
only basic (blue), hydrophobic (yellow), and Phe (magenta) residues are
boxed. (B) Neighbor joining tree illustrating the phylogenetic
relationships of the 4HBMs; tree is based on sequence pairwise
identity. (C) Structural alignment of ﬁve different crystallized and
modeled 4HBMs shows nearly complete overlap for all of the
homologs, regardless of their primary amino acid sequence or
associated catalytic domain.
T3SS itself (Panina et al., 2005). In an effort to characterize the
intracellular localization of BteA, the N-terminal 130aa was found
to contain anMLD and was necessary and sufﬁcient to target GFP
to the lipid raft portion of the HeLa cell membrane (Figure 2;
French et al., 2009). Since it targets a speciﬁc portion of the PM,
which distinguishes it from other known MLDs, the BteA MLD
was therefore termed the lipid raft-targeting domain (LRT).
Further examination of the sequence of the BteA LRT domain
shows that it has a similar composition to other identiﬁed MLDs:
BteA is rich in highly hydrophobic (∼20% are Ile, Leu, Val) and
positively charged (>10% are Arg, Lys) residues (Table 2). BLAST
searches revealed that the central 78aa of this region (aa34–112)
were homologous to 8 other proteins in the database (French et al.,
2009). Two of these homologs are found within predicted T3SS
effectors from P. luminescens, while the other 6 are found inside
MARTX toxins.GFP-fusions to twoother BteA-like LRThomologs
displayed comparable localization patterns as BteALRT-GFP, indi-
cating that there is functional conservation amongst the domains
and that these are a new family of MLDs that target eukaryotic
membrane rafts (French et al., 2009).
Despite having a novelMLD, BteA displays many similarities to
other effectors that possess dedicated MLDs. Expression of BteA
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lacking its targeting domain displayed toxicity indistinguishable
from full-length BteA when it was expressed in the cell at high
levels via transfection. However, BteA ΔLRT-GFP was unable to
be detected in the membrane fraction (French et al., 2009). These
results show that the LRT and catalytic domains of BteA are sep-
arable and that BteA can still identify its target when expressed
at high levels. It remains to be seen if deletion of the LRT will
abolish the toxicity of BteA or the other LRT domain-containing
effectors. Thus, although much is known about the BteA-family
LRT domains there aremany unanswered questions, including the
mechanism of the LRT-PM association.
Several BteA-like LRTMLDs are present inMARTX toxins pro-
duced byVibrio splendidus and the insect pathogens P. luminescens
and P. asymbiotica (French et al., 2009). Interestingly, the putative
effectors attached to these MLDs show no similarity with the cat-
alytic portion of BteA or other known effectors, and are yet to have
any ascribed function (French et al., 2009; Satchell, 2011). Despite
the lack of knowledge of their associated effectors, the localiza-
tion of the isolated LRT domain from one of the P. luminescence
MARTX toxin effectors was similar to that of BteA. Therefore, this
family of LRTdomains is likely functionally conserved across toxin
types and the effectors attached to the BteA-like LRT domains
likely assert their toxicity through direct contact with PM lipid
rafts or raft-associated proteins (French et al., 2009).
These differently sized,mostly unrelated bacterial motifs found
attached to distinct types of enzymes represent assorted domains
that are each able to independently identify the eukaryotic PM.
Despite these differences, all of theseMLDs likely serve to enhance
the natural afﬁnity of their cognate catalytic domains for their
membrane-bound targets in order to promote bacterial infection
and disease.
ADDITIONAL MEANS OF REGULATING INTRACELLULAR
TARGETING
Apart from the host cell modiﬁcations and dedicated MLDs
responsible for intracellular targeting, additional structural motifs
that affect localizationhave been identiﬁedwithin several effectors.
While these motifs have not necessarily been shown to indepen-
dently localize to the PM, they have been shown to affect the
localization of their associated effectors.
COILED-COILS ASSIST PM TARGETING
In general, coiled-coil motifs are thought to mediate protein–
protein binding through interactions between the amphipathic
a-helices that make up these domains (Burkhard et al., 2001).
In silico analysis performed using two independent prediction
programs found that of the 39 Salmonella T3SS1 and T3SS2
effectors analyzed, 19 are predicted to contain putative coiled-coil
domains. Of these coiled-coil containing effectors, 12 had previ-
ously been shown to bemembrane-associated, including SopB (see
Knodler et al., 2011 for speciﬁc proteins and references).Mutations
designed to interrupt the structure of the coiled-coils completely
abolished the targeting and membrane localization of four dif-
ferent Salmonella effectors, highlighting the importance of these
domains for proper targeting. Despite this, GFP-fusions to the iso-
lated coiled-coil were strictly cytosolic, indicating that they were
necessary but not sufﬁcient formembrane association. Coiled-coil
domain swapping experiments between the effectors were unsuc-
cessful, showing that each effector relies upon its cognate coiled-
coil motif and that they are not functionally interchangeable.
Interestingly, these motifs do not overlap with any of the charac-
terized effector-targeting/chaperone-binding regions (see below),
suggesting that coiled-coil domains either represent an additional
level of spatial regulation or that they are simply employed by
several PM-associated effectors for binding their target (Figure 2).
CHAPERONE-BINDING AND MEMBRANE LOCALIZATION
In addition to possessing signal sequences, sub-cellular targeting
motifs, and catalytic domains, speciﬁc binding sites for indi-
vidual chaperone proteins have also been found within several
T3SS effectors. Although no speciﬁc function has been conﬁrmed,
chaperone-binding is thought to play a variety of roles in the
delivery of their associated effectors into the host cell including;
identiﬁcation of the T3SS apparatus within the bacterial cell (Bir-
talan et al., 2002), structural maintenance of the effectors prior to
export (Luo et al., 2001; Page et al., 2002), facilitating transport
through the T3SS needle (Zheng et al., 2012), and inﬂuencing the
order in which the effectors are delivered (Boyd et al., 2000). Inter-
estingly, the chaperone-binding site (CBS) often overlaps with the
MLD within effectors (Boyd et al., 2000; Birtalan et al., 2002; Let-
zelter et al., 2006). The MLD from YopO/YpkA, a Rho-targeting
effector produced by Yersinia, completely coincides with the CBS.
The YopO/YpkA MLD spans residues 20–90 and is rich in I/L
and K/R residues (Table 2), whereas residues 20–77 are essen-
tial for chaperone-binding (Figure 2; Letzelter et al., 2006). The
CBS is also found within the BteA LRT domain (French et al.,
2009), suggesting that coordination of chaperone-binding and
intracellular targeting is a conserved strategy utilized by different
classes of effectors. In support of the predicted roles for chaper-
ones in T3SS, deletion of the YopO/YpkA shared MLD/CBS motif
prevents the export and translocation of their associated effec-
tors (Boyd et al., 2000), although the MLD/CBS are not required
for proper delivery as some effectors are still translocated when
their MLD/CBS are deleted (Letzelter et al., 2006). This over-
lap between the MLD and CBS suggests that, due to its highly
hydrophobic/charged nature, the MLD is likely a favorable spot
for chaperone-binding along with membrane association. How-
ever, further biochemical and biophysical studies are warranted to
determine the role of chaperone-binding to effector intracellular
targeting within the host.
TOPICS FOR FURTHER CONSIDERATION AND CONCLUDING
REMARKS
The wide array of PM targeting mechanisms and dedicated MLDs
that bacterial effectors utilize to identify the host cell PM and/or
their PM-associated targets highlight the importance of spatial
recognition to effector function. This is superbly illustrated in
the ﬁndings that several bacterial effectors are no longer toxic to
cells when their targeting motifs are removed, despite not affect-
ing their catalytic abilities. While all effectors possess a certain
afﬁnity for their substrates, directing their localization to these
targets circumvents the crowded environment of a cell and can
enhance catalysis. Still, several membrane-associated effectors are
able to identify their substrate by possessing a strong afﬁnity for
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their target or having a dedicated binding site associated with the
catalytic site. Determining the contribution of these afﬁnities to
intracellular targeting will further clarify the roles of dedicated
targeting motifs.
The presence of so many effectors that utilize different host cell
enzyme modiﬁcations for mediating their intracellular targeting
shows how pathogens have evolved their virulence repertoire to
effectively modulate host functions. Conservation of these lipida-
tion motifs sites also suggests that these sites have been selected
for or acquired during frequent contact with their hosts. The fact
that these effectors are produced by both extra- and intracellular
pathogens of animals, plants, and insects is intriguing and pro-
vides additional evidence of pathogens evolving to mediate their
survival and occupy speciﬁc environmental/host niches. Further-
more, the varied types of effectors that utilize these short sequences
for modiﬁcations illustrates the effectiveness of this strategy for
identifying substrates and shows that effector-targeting can be
streamlined to avoid integration of complex mechanisms of tar-
geting. In depth genetic analyses are needed to identify the ori-
gins of these motifs and to determine how they have become
so widely distributed amongst so many diverse bacterial species
and toxins.
Similarly, the assortment of different dedicated MLDs, the
range of sizes, and mechanisms of intracellular effector-targeting
is somewhat surprising given that they all seem to be directed
to similar locations. This can be explained by the presence of
additional targeting components apart from what is sufﬁcient
to identify the PM, such as inclusion of hydrophobic/charged
motifs, coiled-coil domains, and/or ubiquitination motifs. These
additional mechanisms likely provide information necessary for
site-speciﬁc targeting, following their initial association with the
PM. Catalytic domains themselves can also inﬂuence spatial speci-
ﬁcity because they have distinct binding partners and substrates.
This is evident in the variety of toxic catalytic domains that are
delivered by shared MLDs, such as those attached to the 4HBMs.
Although they are presumably directed to similar intracellular
locations by the same mechanism, their catalytic domains have
completely different PM-associated targets (Just et al., 1995; Shea-
han and Satchell, 2007; Orth et al., 2009; Geissler et al., 2010).
Despite the lack of information regarding their activities or intra-
cellular targets, this is also likely the case with the BteA-like LRTs
and their associated catalytic domains, because sequence compar-
isons show limited homology downstream of the LRTs (French
et al., 2009). For these two families of MLDs,multiple recombina-
tion events have likely occurred between several different bacteria
and types of toxins in order to generate the diversity of catalytic
domains associated with these conserved MLDs.
Although several functionally interchangeable effector-
targeting mechanisms have been identiﬁed, many motifs are
effector-speciﬁc. It remains to be seen how these strategies are
capable of delivering their cognate toxic cargoes to speciﬁc sites
within the cell, how these mechanisms differ from other MLDs,
and why the speciﬁc sites are targeted. In addition, given the
importance of modulating host cellmembranes for bacterial infec-
tion/persistence, as more effectors involved in virulence are iden-
tiﬁed, additional novel and universal PM targeting motifs are also
likely to be identiﬁed.
With the structural and biochemical data that has been gath-
ered as well as the computational and biophysical tools avail-
able, it appears that further characterization of bacterial effector-
membrane interactions at the molecular level is imminent. Deter-
mination of the binding mechanisms, origins of these domains,
and the transfer/recombination events that led to their associa-
tion with different catalytic domains will be required to resolve
how assorted toxins produced by phylogenetically diverse bac-
teria employ similar targeting domains. Understanding these
interactions will provide further insight into the pathogenesis of
numerous medically and agriculturally relevant pathogens.
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